Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 18/20 | 0.37 |
| ▸ | SLC2A3 | P11169 | 18/20 | 0.37 |
| ▸ | SLC2A4 | P14672 | 17/20 | 0.37 |
| ▸ | SLC2A2 | P11168 | 9/20 | 0.37 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12117282 | 0.95 | SLC2A1 (0.35) | SLC2A1SLC2A3SLC2A4SLC2A2DHODH | |
| SCHEMBL12113462 | 0.95 | SLC2A1 (0.35) | SLC2A1SLC2A3SLC2A4SLC2A2DHODH | |
| SCHEMBL12112960 | 0.94 | SLC2A1 (0.33) | SLC2A1SLC2A3SLC2A4SLC2A2DHODH | |
| SCHEMBL12117091 | 0.94 | SLC2A1 (0.34) | SLC2A1SLC2A3SLC2A4SLC2A2DHODH | |
| SCHEMBL12113378 | 0.93 | SLC2A1 (0.36) | SLC2A1SLC2A3SLC2A4SLC2A2DHODH | |
| SCHEMBL12113372 | 0.93 | SLC2A1 (0.36) | SLC2A1SLC2A3SLC2A4SLC2A2DHODH | |
| SCHEMBL12113394 | 0.93 | SLC2A1 (0.36) | SLC2A1SLC2A3SLC2A4SLC2A2DHODH | |
| SCHEMBL12113379 | 0.93 | SLC2A1 (0.36) | SLC2A1SLC2A3SLC2A4SLC2A2DHODH | |
| SCHEMBL12113392 | 0.93 | SLC2A1 (0.41) | SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL12112900 | 0.93 | SLC2A1 (0.36) | SLC2A1SLC2A3SLC2A4SLC2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8536202-B2 | Triazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2013-09-17 | — | — | US | disclosed |
| US-8536202-B2 | Triazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2013-09-17 | — | — | US | disclosed |
| US-20110275676-A1 | Triazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2011-11-10 | — | — | US | disclosed |
| US-20110275676-A1 | Triazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2011-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275676-A1 | Triazole-substituted anthranilamides as pesticides | AADAC, NAAA, ANTXR2 | SLC2A1 4803/4885SLC2A3 4685/4885SLC2A4 4817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.